CICIHealthcare · Healthcare Plans

CI Stock Forecast: The Cigna Group Price Predictions for 2026-2027

Last close, 4 Nov 2026
$305
+3.38% on the day

The 24 Wall Street analysts covering The Cigna Group hold a median 12-month price target of $345 — +13.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 77 of 100 as at 4 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$78.1B
Ticker Nerd rank
77/ 100
Median analyst target
$345
Analysts covering
24
Revenue$71.4B+6.7% y/y
Operating income$2.4B
Net income$1.9B
Free cash flow−$718.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+3.5%
1M
+12.9%
YTD
+12.8%
1Y
+18.0%
From 52W high
−3.3%
From 52W low
+21.8%
$251
$316
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Cigna Group on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 4 Nov 2026
77/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
99
Value
97
Revisions
81
Growth
80
Issuance
71
Momentum
50
Quality
48
Accruals
39
Size
4

Volatility (99): The share price has been relatively steady.

Accruals (39): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$250$300$350$400Jan 26Apr 26Jul 26Oct 26CIHigh $400Median $345Low $288

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says24 analysts
17 Buy7 Hold0 Sell
Low $288Median $345High $400

The green dot is the last close — the median target sits +13.0% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 5 moved their price target up and 2 moved it down.

DateFirmActionRatingTarget
2 Oct 2026Piper SandlerMaintainsOverweight$346 → $370
1 Oct 2026RBC CapitalReiteratesOutperform$337
4 Aug 2026JefferiesDowngradeHold—
4 Aug 2026JefferiesDowngradeHold$336 → $307
3 Aug 2026Raymond JamesDowngradeOutperform—
3 Aug 2026Raymond JamesDowngradeOutperform$350 → $320
31 July 2026BarclaysMaintainsEqual-Weight$304 → $310
31 July 2026BarclaysMaintainsEqual-Weight—
31 July 2026GuggenheimMaintainsBuy—
31 July 2026GuggenheimMaintainsBuy$338 → $361
31 July 2026Wells FargoMaintainsEqual-Weight$305 → $307
31 July 2026Wells FargoMaintainsEqual-Weight—
9 July 2026BernsteinMaintainsOutperform—
9 July 2026BernsteinMaintainsOutperform$371 → $381
8 June 2026MizuhoMaintainsOutperform—
26 May 2026BarclaysDowngradeEqual-Weight—
22 May 2026UBSMaintainsBuy—
20 May 2026Deutsche BankDowngradeHold—
20 May 2026Morgan StanleyMaintainsOverweight—
5 May 2026BernsteinMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, The Cigna Group returned +18.0% against +14.8% for the S&P 500, dividends included.

CI vs S&P 500, last 12 monthsTotal return, rebased to 100
95100105110115120Jan 26Apr 26Jul 26Oct 26CIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+0.3%
Analysts raising
3
Analysts cutting
1
Fundamentals

The Cigna Group (CI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
12.2×

Cheaper than 52% of US stocks

Price / sales
0.3×

Cheaper than 88% of US stocks

Price / book
1.8×

Cheaper than 46% of US stocks

EV / EBITDA
8.1×

Cheaper than 44% of US stocks

Growth & margins
Revenue growth (YoY)
6.7%

Higher than 45% of US stocks

Earnings growth (YoY)
8.4%

Higher than 47% of US stocks

Gross margin
8.8%

Higher than 9% of US stocks

Operating margin
4.0%

Higher than 52% of US stocks

Net margin
2.3%

Higher than 53% of US stocks

Returns & dividend
Return on equity
16.8%

Higher than 77% of US stocks

Return on assets
4.5%

Higher than 73% of US stocks

Dividend yield
2.1%

Higher than 80% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

The Cigna Group (CI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • The Cigna Group has a market value of $78.1B and an enterprise value of $102.9B.

  • Revenue in the twelve months to 30 June 2026: $281.3B. The latest quarter grew 6.7% year on year.

  • Net income over the same four quarters: $7.0B, a 2.5% net margin.

  • Diluted earnings per share, trailing twelve months: $24.17.

  • Free cash flow in the twelve months to 30 June 2026: $9.1B.

  • The Cigna Group spent $1.3B on share buybacks and $1.6B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 263.6M.

  • Trailing P/E: 12.2×; forward P/E: 8.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.11%, paying out 25% of earnings.

  • The Cigna Group employs 65,669 people — $4.3M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 5 Nov 2026

Data provided by Twelve Data

Peers

CI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
CIThe Cigna Group$78.1B77
ELVElevance Health, Inc.$96.5B77
CVSCVS Health Corp.$101.5B79
HUMHumana, Inc.$50.2B51
CNCCentene Corp.$37.4B93
UNHUnitedHealth Group, Inc.$370.8B81
MOHMolina Healthcare, Inc.$11.8B34

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Cigna Group — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CI news & analysis

The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook

PRNewsWire · 5 Nov 2026positive

The Cigna Group reported third-quarter 2026 revenue of $73.7 billion, up 6%, with shareholders’ net income of $1.4 billion and adjusted operating income of $2.1 billion. It raised its 2026 adjusted operating income outlook to at least $30.60 per share and announced long-term targets and a $3 billion modernization and productivity initiative at Investor Day.

Why it matters — The results, higher 2026 outlook, and newly announced long-term targets provide CI watchers with updates on performance and the company’s stated financial priorities.

Cigna Stock Has Gained Since Investor Day. Earnings Are Next.

Barrons · 4 Nov 2026neutral

Cigna shares have gained since Investor Day, with third-quarter earnings next. Analysts expect adjusted earnings per share of $7.52, compared with $7.83 a year earlier.

Why it matters — CI watchers can compare the upcoming earnings report with analysts’ expectation for lower adjusted EPS year over year.

How to Earn $500 A Month From Cigna Stock Ahead Of Q3 Earnings

Benzinga · 4 Nov 2026neutral

A Benzinga headline discusses how investors might earn $500 a month from Cigna stock ahead of the company’s third-quarter earnings report, scheduled for Thursday, Nov. 5. The excerpt says investors may be eyeing potential dividend gains.

Why it matters — CI watchers may be interested in the dividend-focused discussion ahead of the company’s earnings report.

Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?

Zacks Investment Research · 3 Nov 2026neutral

Cigna's Q3 revenue is expected to rise, supported by pharmacy and premium growth, while declining Evernorth profits and higher medical costs could weigh on earnings.

Why it matters — CI watchers may track whether pharmacy and premium growth can offset pressure from Evernorth profits and medical costs.

FAQ

Frequently asked questions about CI stock

What is the CI stock price forecast for 2026-2027?

The 24 Wall Street analysts covering The Cigna Group have a median 12-month price target of $345, with estimates ranging from $288 to $400. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CI stock a buy right now?

Of the 24 analysts covering The Cigna Group, 17 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Cigna Group 77 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CI?

As at 4 Nov 2026, The Cigna Group ranks 77 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).

Will CI stock go up?

No one can know that. What the data says: the median 12-month target from 24 analysts implies +13.0% from the last close, and Ticker Nerd's factor model ranks The Cigna Group 77 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CI stock forecast for 2030?

No analyst covering The Cigna Group publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $288 to $400 over the next 12 months.

How has CI stock performed over the past year?

The Cigna Group returned +18.0% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Cigna Group do?

The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations.

What is the latest news on CI?

The most recent item we track (PRNewsWire, 5 Nov 2026): "The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook". The Cigna Group reported third-quarter 2026 revenue of $73.7 billion, up 6%, with shareholders’ net income of $1.4 billion and adjusted operating income of $2.1 billion. It raised its 2026 adjusted operating income outlook to at least $30.60 per share and announced long-term targets and a $3 billion modernization and productivity initiative at Investor Day.

Company

About The Cigna Group.

The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.

CEO Mr. Brian Case Evanko C.F.A. · 65,669 employees · United States · https://www.thecignagroup.com